Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Barrett Esophagus | 11 | 2009 | 494 | 1.640 |
Why?
|
Colitis | 21 | 2023 | 1149 | 1.320 |
Why?
|
Intestinal Mucosa | 25 | 2023 | 3038 | 1.010 |
Why?
|
Esophagogastric Junction | 6 | 2009 | 312 | 1.010 |
Why?
|
Gastritis | 5 | 2015 | 191 | 1.000 |
Why?
|
Metaplasia | 8 | 2007 | 313 | 0.760 |
Why?
|
Gastric Mucosa | 7 | 2015 | 598 | 0.710 |
Why?
|
Colitis, Ulcerative | 12 | 2022 | 1901 | 0.650 |
Why?
|
Helicobacter Infections | 3 | 2015 | 385 | 0.610 |
Why?
|
Epithelium | 7 | 2009 | 1680 | 0.610 |
Why?
|
Cardia | 3 | 2007 | 57 | 0.580 |
Why?
|
Helicobacter pylori | 3 | 2015 | 381 | 0.580 |
Why?
|
Stomach | 3 | 2015 | 697 | 0.550 |
Why?
|
Mucins | 4 | 2010 | 564 | 0.460 |
Why?
|
Fusobacterium nucleatum | 3 | 2021 | 160 | 0.460 |
Why?
|
Colon | 18 | 2023 | 1773 | 0.450 |
Why?
|
Colorectal Neoplasms | 14 | 2022 | 6754 | 0.450 |
Why?
|
Esophageal Neoplasms | 5 | 2007 | 1581 | 0.440 |
Why?
|
Keratins | 6 | 2005 | 515 | 0.440 |
Why?
|
Immunity, Mucosal | 5 | 2019 | 491 | 0.430 |
Why?
|
Esophagus | 5 | 2008 | 1017 | 0.420 |
Why?
|
Pathology, Surgical | 2 | 2023 | 155 | 0.410 |
Why?
|
Adenocarcinoma | 8 | 2018 | 6347 | 0.380 |
Why?
|
Colonic Neoplasms | 6 | 2020 | 2542 | 0.370 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 5 | 2022 | 1038 | 0.370 |
Why?
|
Th17 Cells | 3 | 2023 | 765 | 0.370 |
Why?
|
Adenoma | 6 | 2022 | 2168 | 0.350 |
Why?
|
Gastroesophageal Reflux | 6 | 2009 | 782 | 0.340 |
Why?
|
Intestines | 7 | 2022 | 1923 | 0.340 |
Why?
|
T-Box Domain Proteins | 8 | 2015 | 471 | 0.330 |
Why?
|
Intermediate Filament Proteins | 3 | 2005 | 269 | 0.330 |
Why?
|
Tissue Fixation | 3 | 2008 | 241 | 0.320 |
Why?
|
Rectum | 5 | 2018 | 903 | 0.320 |
Why?
|
Immunohistochemistry | 19 | 2015 | 11363 | 0.310 |
Why?
|
Pleural Neoplasms | 6 | 2009 | 607 | 0.300 |
Why?
|
Mice | 68 | 2023 | 81045 | 0.300 |
Why?
|
Esophageal Diseases | 2 | 2005 | 165 | 0.290 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2020 | 1366 | 0.290 |
Why?
|
Receptors, Fc | 3 | 2020 | 540 | 0.290 |
Why?
|
Mesothelioma | 7 | 2009 | 818 | 0.290 |
Why?
|
Pancreatic Neoplasms | 11 | 2020 | 5249 | 0.280 |
Why?
|
Mice, Knockout | 26 | 2023 | 14554 | 0.270 |
Why?
|
Dendritic Cells | 7 | 2020 | 2723 | 0.260 |
Why?
|
Biopsy | 12 | 2015 | 6756 | 0.260 |
Why?
|
Receptors, Cell Surface | 3 | 2021 | 2867 | 0.230 |
Why?
|
Precancerous Conditions | 3 | 2007 | 971 | 0.230 |
Why?
|
Carcinoma, Pancreatic Ductal | 5 | 2020 | 1631 | 0.230 |
Why?
|
Animals | 76 | 2023 | 168561 | 0.230 |
Why?
|
Tomography, X-Ray Computed | 20 | 2020 | 20086 | 0.220 |
Why?
|
Stomach Diseases | 1 | 2003 | 134 | 0.210 |
Why?
|
Interleukin-10 Receptor alpha Subunit | 1 | 2022 | 27 | 0.210 |
Why?
|
Endometriosis | 2 | 2020 | 834 | 0.210 |
Why?
|
Antigens, CD1d | 5 | 2018 | 220 | 0.200 |
Why?
|
Interleukin-17 | 2 | 2021 | 900 | 0.200 |
Why?
|
Helicobacter | 1 | 2021 | 112 | 0.200 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2003 | 4029 | 0.200 |
Why?
|
Heme | 1 | 2023 | 307 | 0.200 |
Why?
|
Hemolysis | 1 | 2023 | 420 | 0.190 |
Why?
|
Tryptophanase | 1 | 2020 | 6 | 0.190 |
Why?
|
Mannose-Binding Lectins | 1 | 2021 | 100 | 0.190 |
Why?
|
Receptors, CCR2 | 1 | 2022 | 212 | 0.190 |
Why?
|
Inflammation | 13 | 2023 | 10578 | 0.190 |
Why?
|
Digestive System | 1 | 2001 | 251 | 0.190 |
Why?
|
Epithelial Cells | 5 | 2022 | 3678 | 0.190 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2020 | 68 | 0.190 |
Why?
|
Listeriosis | 1 | 2021 | 149 | 0.180 |
Why?
|
Gastroscopy | 1 | 2001 | 206 | 0.180 |
Why?
|
Disease Models, Animal | 25 | 2021 | 18006 | 0.180 |
Why?
|
Humans | 125 | 2023 | 742088 | 0.180 |
Why?
|
Lymphocytes | 3 | 2020 | 2614 | 0.170 |
Why?
|
Tretinoin | 1 | 2022 | 516 | 0.170 |
Why?
|
Escherichia coli | 4 | 2023 | 4214 | 0.170 |
Why?
|
DNA, Neoplasm | 2 | 2007 | 1758 | 0.170 |
Why?
|
Enterobacteriaceae | 2 | 2010 | 169 | 0.170 |
Why?
|
Immunity, Innate | 4 | 2020 | 2956 | 0.170 |
Why?
|
Mice, Inbred BALB C | 14 | 2017 | 6382 | 0.170 |
Why?
|
Trans-Activators | 3 | 2009 | 2924 | 0.170 |
Why?
|
Inflammatory Bowel Diseases | 6 | 2015 | 2410 | 0.170 |
Why?
|
Oligosaccharides | 1 | 2021 | 414 | 0.170 |
Why?
|
Abdominal Wall | 1 | 2020 | 155 | 0.170 |
Why?
|
Carcinoembryonic Antigen | 3 | 2006 | 347 | 0.160 |
Why?
|
Diagnosis, Differential | 15 | 2020 | 12958 | 0.160 |
Why?
|
Endoplasmic Reticulum | 3 | 2017 | 1144 | 0.160 |
Why?
|
Genetic Markers | 2 | 2007 | 2633 | 0.160 |
Why?
|
Smad4 Protein | 1 | 2018 | 163 | 0.160 |
Why?
|
Microsatellite Instability | 2 | 2020 | 678 | 0.160 |
Why?
|
Mice, Inbred C57BL | 21 | 2023 | 21821 | 0.160 |
Why?
|
Lectins, C-Type | 1 | 2021 | 588 | 0.150 |
Why?
|
Mast Cells | 3 | 2010 | 1544 | 0.150 |
Why?
|
Eosinophils | 1 | 2022 | 953 | 0.150 |
Why?
|
Female | 80 | 2022 | 379592 | 0.150 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2021 | 1221 | 0.150 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2017 | 91 | 0.150 |
Why?
|
Sigmoidoscopy | 3 | 2008 | 156 | 0.150 |
Why?
|
DNA-Binding Proteins | 14 | 2015 | 9639 | 0.150 |
Why?
|
Oxazoles | 1 | 2018 | 189 | 0.150 |
Why?
|
Male | 68 | 2022 | 349538 | 0.150 |
Why?
|
Gallstones | 2 | 2010 | 286 | 0.140 |
Why?
|
Gene Expression Profiling | 8 | 2009 | 9410 | 0.140 |
Why?
|
Glycoproteins | 2 | 2021 | 2260 | 0.140 |
Why?
|
Gastrointestinal Neoplasms | 4 | 2012 | 987 | 0.140 |
Why?
|
Membrane Proteins | 7 | 2021 | 7873 | 0.140 |
Why?
|
Esophagoscopy | 2 | 2009 | 390 | 0.140 |
Why?
|
Intestinal Diseases | 2 | 2013 | 531 | 0.140 |
Why?
|
Bacteria | 4 | 2021 | 2102 | 0.140 |
Why?
|
Interleukins | 2 | 2020 | 791 | 0.140 |
Why?
|
Natural Killer T-Cells | 3 | 2018 | 315 | 0.140 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2018 | 209 | 0.140 |
Why?
|
Middle Aged | 48 | 2020 | 213127 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 14 | 2020 | 35342 | 0.140 |
Why?
|
Crohn Disease | 5 | 2019 | 2301 | 0.140 |
Why?
|
Mice, Transgenic | 11 | 2023 | 9735 | 0.140 |
Why?
|
Intestinal Neoplasms | 3 | 2008 | 319 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2013 | 8425 | 0.130 |
Why?
|
Quorum Sensing | 1 | 2016 | 131 | 0.130 |
Why?
|
Paneth Cells | 2 | 2013 | 100 | 0.130 |
Why?
|
Lactococcus lactis | 1 | 2015 | 28 | 0.130 |
Why?
|
Immunoglobulin A | 1 | 2019 | 992 | 0.130 |
Why?
|
Dietary Proteins | 1 | 2020 | 963 | 0.130 |
Why?
|
Muramidase | 1 | 2015 | 174 | 0.130 |
Why?
|
Keratin-20 | 3 | 2005 | 31 | 0.130 |
Why?
|
Disease Susceptibility | 5 | 2020 | 1780 | 0.130 |
Why?
|
Th1 Cells | 2 | 2019 | 1056 | 0.130 |
Why?
|
Fundoplication | 2 | 2007 | 138 | 0.130 |
Why?
|
Keratin-7 | 3 | 2005 | 57 | 0.130 |
Why?
|
Graft vs Host Disease | 5 | 2006 | 2951 | 0.130 |
Why?
|
Autoimmunity | 2 | 2020 | 1348 | 0.120 |
Why?
|
Muscle, Smooth | 3 | 2008 | 933 | 0.120 |
Why?
|
Polysaccharides | 1 | 2021 | 1051 | 0.120 |
Why?
|
Macrophages | 4 | 2023 | 5655 | 0.120 |
Why?
|
Immunoglobulin G | 3 | 2020 | 4554 | 0.120 |
Why?
|
Gastrointestinal Diseases | 3 | 2009 | 1167 | 0.120 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2009 | 484 | 0.120 |
Why?
|
Tomography, Spiral Computed | 3 | 2004 | 279 | 0.120 |
Why?
|
Genes, Tumor Suppressor | 3 | 2005 | 1097 | 0.120 |
Why?
|
DNA Methylation | 4 | 2020 | 4282 | 0.120 |
Why?
|
Homeostasis | 4 | 2022 | 3335 | 0.120 |
Why?
|
Prognosis | 15 | 2022 | 29010 | 0.120 |
Why?
|
Cyclooxygenase 2 | 3 | 2020 | 611 | 0.120 |
Why?
|
Transcription Factors | 9 | 2013 | 12164 | 0.120 |
Why?
|
Carrier Proteins | 6 | 2017 | 5019 | 0.110 |
Why?
|
Proctitis | 2 | 2003 | 40 | 0.110 |
Why?
|
Colonic Polyps | 2 | 2009 | 542 | 0.110 |
Why?
|
Cell Adhesion Molecules | 2 | 2014 | 1599 | 0.110 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2014 | 143 | 0.110 |
Why?
|
Genes, ras | 2 | 2008 | 691 | 0.110 |
Why?
|
Aspirin | 2 | 2021 | 3278 | 0.110 |
Why?
|
Aged | 34 | 2020 | 162944 | 0.110 |
Why?
|
Carcinoma, Papillary | 3 | 2009 | 781 | 0.110 |
Why?
|
Fatty Acids, Volatile | 1 | 2013 | 101 | 0.110 |
Why?
|
Mucin-2 | 2 | 2009 | 49 | 0.110 |
Why?
|
Chemokine CCL2 | 1 | 2015 | 617 | 0.110 |
Why?
|
Interleukin-10 | 2 | 2018 | 1200 | 0.110 |
Why?
|
Phosphoproteins | 1 | 2001 | 2440 | 0.110 |
Why?
|
Immunoenzyme Techniques | 5 | 2008 | 1799 | 0.110 |
Why?
|
Liver Neoplasms | 5 | 2008 | 4249 | 0.110 |
Why?
|
Carcinoid Tumor | 2 | 2006 | 235 | 0.110 |
Why?
|
Superoxide Dismutase | 1 | 2015 | 596 | 0.110 |
Why?
|
Genes, p53 | 2 | 2006 | 755 | 0.110 |
Why?
|
Appendicitis | 2 | 2009 | 644 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1989 | 0.110 |
Why?
|
Monocytes | 1 | 2022 | 2593 | 0.100 |
Why?
|
Genomic Instability | 2 | 2007 | 695 | 0.100 |
Why?
|
Germ-Free Life | 3 | 2021 | 188 | 0.100 |
Why?
|
Neoplasm Proteins | 4 | 2009 | 3691 | 0.100 |
Why?
|
Adult | 42 | 2020 | 213712 | 0.100 |
Why?
|
Mutation | 7 | 2008 | 29717 | 0.100 |
Why?
|
Malignant Carcinoid Syndrome | 2 | 2008 | 31 | 0.100 |
Why?
|
Lipoma | 2 | 2004 | 334 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2018 | 9185 | 0.100 |
Why?
|
Receptors, Virus | 1 | 2014 | 648 | 0.100 |
Why?
|
Proteus mirabilis | 1 | 2010 | 25 | 0.100 |
Why?
|
Feces | 4 | 2019 | 1394 | 0.100 |
Why?
|
Signal Transduction | 8 | 2023 | 23387 | 0.090 |
Why?
|
T-Lymphocytes | 6 | 2014 | 10163 | 0.090 |
Why?
|
Chromosomes, Mammalian | 1 | 2011 | 151 | 0.090 |
Why?
|
Proteome | 1 | 2020 | 1790 | 0.090 |
Why?
|
Antigens, CD1 | 2 | 2004 | 437 | 0.090 |
Why?
|
Cystic Fibrosis | 2 | 2010 | 1178 | 0.090 |
Why?
|
Receptors, IgG | 2 | 2020 | 582 | 0.090 |
Why?
|
Hyperplasia | 4 | 2008 | 1183 | 0.090 |
Why?
|
Celiac Disease | 2 | 2009 | 785 | 0.090 |
Why?
|
Bifidobacterium | 1 | 2010 | 100 | 0.090 |
Why?
|
Microbial Interactions | 1 | 2010 | 76 | 0.090 |
Why?
|
Trinitrobenzenesulfonic Acid | 2 | 2010 | 68 | 0.090 |
Why?
|
Antigens, CD | 3 | 2014 | 4024 | 0.090 |
Why?
|
Retrospective Studies | 19 | 2023 | 77098 | 0.090 |
Why?
|
Liver Cirrhosis | 3 | 2009 | 1864 | 0.090 |
Why?
|
Metagenome | 1 | 2013 | 417 | 0.090 |
Why?
|
Escherichia coli Proteins | 1 | 2016 | 1052 | 0.090 |
Why?
|
Pancreas | 4 | 2009 | 1684 | 0.090 |
Why?
|
Membrane Transport Proteins | 2 | 2008 | 1028 | 0.090 |
Why?
|
Tryptases | 1 | 2010 | 190 | 0.090 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2010 | 132 | 0.090 |
Why?
|
Gene Expression Regulation | 8 | 2015 | 12071 | 0.090 |
Why?
|
Mixed Tumor, Malignant | 1 | 2009 | 15 | 0.090 |
Why?
|
Protein Isoforms | 2 | 2006 | 1727 | 0.090 |
Why?
|
Disease Progression | 8 | 2020 | 13256 | 0.090 |
Why?
|
Aged, 80 and over | 14 | 2015 | 57683 | 0.090 |
Why?
|
Bile | 1 | 2010 | 296 | 0.080 |
Why?
|
Aminosalicylic Acid | 1 | 2008 | 21 | 0.080 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 2 | 2006 | 122 | 0.080 |
Why?
|
Cromolyn Sodium | 1 | 2009 | 87 | 0.080 |
Why?
|
Portal Vein | 2 | 2001 | 437 | 0.080 |
Why?
|
Bone Marrow Cells | 2 | 2014 | 2513 | 0.080 |
Why?
|
Taurocholic Acid | 1 | 2008 | 43 | 0.080 |
Why?
|
Mucous Membrane | 2 | 2014 | 670 | 0.080 |
Why?
|
Klebsiella pneumoniae | 1 | 2010 | 246 | 0.080 |
Why?
|
Telomere | 2 | 2006 | 909 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2008 | 2211 | 0.080 |
Why?
|
Cholelithiasis | 1 | 2010 | 411 | 0.080 |
Why?
|
Gallbladder | 1 | 2010 | 301 | 0.080 |
Why?
|
Liver | 7 | 2008 | 7470 | 0.080 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2008 | 1341 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2006 | 2948 | 0.080 |
Why?
|
Bilirubin | 1 | 2010 | 424 | 0.080 |
Why?
|
Laparoscopy | 1 | 2020 | 2121 | 0.080 |
Why?
|
STAT3 Transcription Factor | 3 | 2019 | 874 | 0.080 |
Why?
|
RNA, Small Nuclear | 1 | 1988 | 65 | 0.080 |
Why?
|
Fatty Liver | 2 | 2006 | 728 | 0.080 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2009 | 505 | 0.080 |
Why?
|
Contrast Media | 8 | 2020 | 5295 | 0.080 |
Why?
|
Mass Screening | 1 | 2003 | 5238 | 0.080 |
Why?
|
RNA, Neoplasm | 5 | 2008 | 768 | 0.080 |
Why?
|
Ectodermal Dysplasia | 1 | 2008 | 103 | 0.080 |
Why?
|
Hepatic Veins | 1 | 2008 | 112 | 0.080 |
Why?
|
Lymphocytosis | 1 | 2008 | 119 | 0.080 |
Why?
|
Lymphocyte Activation | 3 | 2019 | 5519 | 0.080 |
Why?
|
Hematopoietic System | 1 | 2007 | 108 | 0.080 |
Why?
|
Clathrin | 1 | 1989 | 265 | 0.080 |
Why?
|
Biopsy, Needle | 4 | 2012 | 1640 | 0.080 |
Why?
|
Gastrointestinal Tract | 1 | 2014 | 814 | 0.080 |
Why?
|
Milk | 1 | 2010 | 449 | 0.080 |
Why?
|
Immunity | 1 | 2013 | 1011 | 0.080 |
Why?
|
I-kappa B Kinase | 1 | 2008 | 251 | 0.070 |
Why?
|
Fatty Acid Desaturases | 1 | 2007 | 102 | 0.070 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2006 | 290 | 0.070 |
Why?
|
Brenner Tumor | 1 | 2006 | 8 | 0.070 |
Why?
|
Bile Ducts | 1 | 2008 | 284 | 0.070 |
Why?
|
Hepatitis, Autoimmune | 1 | 2008 | 141 | 0.070 |
Why?
|
Diet | 3 | 2022 | 7923 | 0.070 |
Why?
|
Oxazolone | 3 | 2014 | 60 | 0.070 |
Why?
|
Frozen Sections | 1 | 2007 | 155 | 0.070 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2009 | 472 | 0.070 |
Why?
|
Chilblains | 1 | 2006 | 14 | 0.070 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2009 | 647 | 0.070 |
Why?
|
Administration, Topical | 1 | 2008 | 688 | 0.070 |
Why?
|
Ligands | 4 | 2021 | 3293 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2195 | 0.070 |
Why?
|
Polyps | 1 | 2007 | 189 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3564 | 0.070 |
Why?
|
Bile Acids and Salts | 1 | 2008 | 353 | 0.070 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2007 | 215 | 0.070 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2005 | 76 | 0.070 |
Why?
|
Retinoblastoma-Like Protein p107 | 1 | 2005 | 74 | 0.070 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2012 | 642 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2009 | 638 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2014 | 2257 | 0.070 |
Why?
|
Dextran Sulfate | 2 | 2020 | 236 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2005 | 78 | 0.070 |
Why?
|
Cell Differentiation | 7 | 2023 | 11470 | 0.060 |
Why?
|
Reproducibility of Results | 7 | 2009 | 19862 | 0.060 |
Why?
|
CpG Islands | 1 | 2009 | 1170 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2009 | 774 | 0.060 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2006 | 191 | 0.060 |
Why?
|
Ribonucleoproteins | 1 | 1988 | 381 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 4 | 2007 | 2842 | 0.060 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2006 | 295 | 0.060 |
Why?
|
RNA, Messenger | 6 | 2008 | 13029 | 0.060 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2008 | 546 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7167 | 0.060 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2006 | 171 | 0.060 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2008 | 370 | 0.060 |
Why?
|
Proline | 1 | 2006 | 458 | 0.060 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2005 | 61 | 0.060 |
Why?
|
Statistics, Nonparametric | 3 | 2022 | 2885 | 0.060 |
Why?
|
Mitosis | 2 | 2007 | 1208 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2008 | 5425 | 0.060 |
Why?
|
Sensitivity and Specificity | 6 | 2020 | 14720 | 0.060 |
Why?
|
Cytokines | 6 | 2021 | 7317 | 0.060 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2006 | 220 | 0.060 |
Why?
|
Virus Diseases | 1 | 2010 | 710 | 0.060 |
Why?
|
Homeodomain Proteins | 3 | 2009 | 2417 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2007 | 859 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2015 | 2217 | 0.060 |
Why?
|
Esophagectomy | 1 | 2007 | 447 | 0.060 |
Why?
|
Dermoid Cyst | 1 | 2004 | 92 | 0.060 |
Why?
|
Lymphocyte Count | 2 | 2020 | 792 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2006 | 1114 | 0.060 |
Why?
|
Hemopexin | 1 | 2023 | 33 | 0.060 |
Why?
|
Pancreatitis | 2 | 2008 | 1090 | 0.060 |
Why?
|
Pleura | 1 | 2004 | 235 | 0.060 |
Why?
|
Genes, APC | 1 | 2003 | 159 | 0.060 |
Why?
|
Receptors, Interleukin-10 | 1 | 2023 | 50 | 0.060 |
Why?
|
Endopeptidases | 1 | 2007 | 772 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2011 | 2015 | 0.060 |
Why?
|
Meckel Diverticulum | 1 | 2002 | 34 | 0.060 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2004 | 111 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2009 | 1121 | 0.050 |
Why?
|
Atrophy | 1 | 2007 | 1576 | 0.050 |
Why?
|
Gastric Fundus | 1 | 2002 | 39 | 0.050 |
Why?
|
Vaginal Neoplasms | 1 | 2003 | 106 | 0.050 |
Why?
|
Cystadenoma, Serous | 1 | 2003 | 102 | 0.050 |
Why?
|
Herpesvirus 4, Human | 1 | 1988 | 1040 | 0.050 |
Why?
|
Kidney Neoplasms | 2 | 2009 | 4229 | 0.050 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 627 | 0.050 |
Why?
|
Antigens, Differentiation | 2 | 2004 | 926 | 0.050 |
Why?
|
Citrobacter rodentium | 1 | 2022 | 65 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2023 | 2638 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2009 | 4751 | 0.050 |
Why?
|
Proctocolitis | 1 | 2002 | 25 | 0.050 |
Why?
|
Colitis, Ischemic | 1 | 2002 | 31 | 0.050 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2001 | 31 | 0.050 |
Why?
|
Receptors, Cytokine | 1 | 2002 | 261 | 0.050 |
Why?
|
Intestine, Small | 1 | 2008 | 1243 | 0.050 |
Why?
|
Neuroendocrine Tumors | 1 | 2008 | 594 | 0.050 |
Why?
|
Acute Disease | 4 | 2009 | 7141 | 0.050 |
Why?
|
Child, Preschool | 7 | 2009 | 40955 | 0.050 |
Why?
|
Fermentation | 2 | 2013 | 143 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2009 | 3920 | 0.050 |
Why?
|
Mesenteric Veins | 1 | 2001 | 89 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2021 | 3617 | 0.050 |
Why?
|
Mice, Mutant Strains | 4 | 2007 | 1866 | 0.050 |
Why?
|
Chromosome Aberrations | 1 | 2008 | 1811 | 0.050 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2004 | 324 | 0.050 |
Why?
|
Necrosis | 2 | 2020 | 1643 | 0.050 |
Why?
|
Observer Variation | 1 | 2007 | 2593 | 0.050 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2001 | 97 | 0.050 |
Why?
|
Embolism, Air | 1 | 2001 | 111 | 0.050 |
Why?
|
Macrophages, Peritoneal | 1 | 2002 | 251 | 0.050 |
Why?
|
Bone Marrow Transplantation | 3 | 2003 | 2763 | 0.050 |
Why?
|
Esophagitis | 1 | 2002 | 152 | 0.050 |
Why?
|
Endoscopy, Digestive System | 1 | 2004 | 345 | 0.050 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2004 | 986 | 0.050 |
Why?
|
Mucus | 1 | 2022 | 321 | 0.050 |
Why?
|
Gases | 1 | 2001 | 197 | 0.050 |
Why?
|
Neoplasm Staging | 5 | 2012 | 11001 | 0.050 |
Why?
|
Indican | 1 | 2020 | 17 | 0.050 |
Why?
|
Insulinoma | 1 | 2001 | 124 | 0.050 |
Why?
|
Cholesterol | 1 | 2010 | 2895 | 0.050 |
Why?
|
Bile Duct Neoplasms | 1 | 2006 | 567 | 0.050 |
Why?
|
Hepatitis | 1 | 2003 | 227 | 0.050 |
Why?
|
Cholangiocarcinoma | 1 | 2006 | 516 | 0.050 |
Why?
|
Ribavirin | 1 | 2003 | 395 | 0.050 |
Why?
|
Opportunistic Infections | 1 | 2004 | 389 | 0.050 |
Why?
|
Eicosapentaenoic Acid | 1 | 2005 | 582 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2007 | 4379 | 0.050 |
Why?
|
Child | 12 | 2009 | 77478 | 0.050 |
Why?
|
Pseudomonas Infections | 2 | 2002 | 608 | 0.050 |
Why?
|
Polymerase Chain Reaction | 5 | 2010 | 6171 | 0.050 |
Why?
|
Mycoses | 1 | 2004 | 376 | 0.050 |
Why?
|
Administration, Oral | 1 | 2008 | 3913 | 0.050 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2007 | 849 | 0.050 |
Why?
|
Toxins, Biological | 1 | 2020 | 66 | 0.050 |
Why?
|
Adolescent | 12 | 2009 | 85649 | 0.050 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2001 | 428 | 0.050 |
Why?
|
Lung | 3 | 2012 | 9826 | 0.050 |
Why?
|
Diphtheria Toxin | 1 | 2021 | 255 | 0.050 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2004 | 600 | 0.050 |
Why?
|
Lectins | 1 | 2022 | 514 | 0.050 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2004 | 324 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13019 | 0.040 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2003 | 334 | 0.040 |
Why?
|
Interferon-gamma | 3 | 2022 | 3199 | 0.040 |
Why?
|
Ovarian Neoplasms | 3 | 2006 | 4823 | 0.040 |
Why?
|
Predictive Value of Tests | 5 | 2009 | 15056 | 0.040 |
Why?
|
Gadolinium | 1 | 2005 | 951 | 0.040 |
Why?
|
Diagnostic Imaging | 2 | 2012 | 3507 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 2986 | 0.040 |
Why?
|
Bone Neoplasms | 1 | 2012 | 2522 | 0.040 |
Why?
|
Ligases | 1 | 2001 | 332 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2008 | 1847 | 0.040 |
Why?
|
Ganglioneuroma | 1 | 1999 | 57 | 0.040 |
Why?
|
Hydrogen Sulfide | 1 | 2020 | 137 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2001 | 644 | 0.040 |
Why?
|
RNA, Viral | 1 | 1988 | 2899 | 0.040 |
Why?
|
Vascular Neoplasms | 1 | 2001 | 175 | 0.040 |
Why?
|
Oncogenes | 1 | 2005 | 1263 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11472 | 0.040 |
Why?
|
Leiomyosarcoma | 1 | 2003 | 477 | 0.040 |
Why?
|
Asthma | 2 | 2012 | 5955 | 0.040 |
Why?
|
Cell Proliferation | 5 | 2021 | 10472 | 0.040 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2020 | 188 | 0.040 |
Why?
|
Prolactinoma | 1 | 1999 | 113 | 0.040 |
Why?
|
Abetalipoproteinemia | 2 | 2004 | 17 | 0.040 |
Why?
|
Autophagy | 2 | 2019 | 1301 | 0.040 |
Why?
|
Bacteroides | 1 | 2019 | 161 | 0.040 |
Why?
|
Extracellular Matrix | 1 | 2006 | 1740 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2003 | 895 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2023 | 4414 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2021 | 2940 | 0.040 |
Why?
|
Chemokines | 2 | 2014 | 954 | 0.040 |
Why?
|
Vagina | 1 | 2003 | 825 | 0.040 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2020 | 402 | 0.040 |
Why?
|
Severity of Illness Index | 6 | 2009 | 15530 | 0.040 |
Why?
|
Glycosylation | 1 | 2021 | 1123 | 0.040 |
Why?
|
Models, Molecular | 2 | 2021 | 5454 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2009 | 3465 | 0.040 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2020 | 338 | 0.040 |
Why?
|
RNA Interference | 2 | 2018 | 2890 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2009 | 3766 | 0.040 |
Why?
|
Specimen Handling | 1 | 2022 | 692 | 0.040 |
Why?
|
Tissue Culture Techniques | 1 | 2019 | 291 | 0.040 |
Why?
|
Permeability | 1 | 2020 | 738 | 0.040 |
Why?
|
Liver Diseases | 1 | 2006 | 1252 | 0.040 |
Why?
|
Th2 Cells | 1 | 2002 | 1049 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2015 | 2077 | 0.040 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 109 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2019 | 418 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1675 | 0.040 |
Why?
|
Nuclear Proteins | 2 | 2002 | 5851 | 0.040 |
Why?
|
Ultrasonography | 5 | 2009 | 5978 | 0.040 |
Why?
|
Carbon Tetrachloride Poisoning | 2 | 2006 | 13 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2020 | 4438 | 0.040 |
Why?
|
Doxorubicin | 1 | 2023 | 2215 | 0.040 |
Why?
|
Flagella | 1 | 2016 | 101 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2023 | 1255 | 0.030 |
Why?
|
Enteritis | 1 | 2017 | 160 | 0.030 |
Why?
|
Proteins | 2 | 2002 | 6096 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 2 | 2009 | 3123 | 0.030 |
Why?
|
Tryptophan | 1 | 2018 | 478 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2001 | 1866 | 0.030 |
Why?
|
Catecholamines | 1 | 2016 | 387 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 890 | 0.030 |
Why?
|
Mitochondrial Proteins | 1 | 2002 | 995 | 0.030 |
Why?
|
Hemangioma | 1 | 2001 | 737 | 0.030 |
Why?
|
Immunomodulation | 1 | 2019 | 540 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 592 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2020 | 712 | 0.030 |
Why?
|
Alleles | 3 | 2019 | 6931 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3444 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2020 | 2028 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2021 | 1692 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6891 | 0.030 |
Why?
|
Synaptophysin | 2 | 2009 | 141 | 0.030 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2004 | 1515 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2003 | 4187 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12344 | 0.030 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2014 | 33 | 0.030 |
Why?
|
beta Catenin | 1 | 2020 | 1058 | 0.030 |
Why?
|
Pseudomonas aeruginosa | 1 | 2002 | 1210 | 0.030 |
Why?
|
HSP110 Heat-Shock Proteins | 1 | 2014 | 10 | 0.030 |
Why?
|
Benzoic Acid | 1 | 2014 | 15 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 4 | 2008 | 17400 | 0.030 |
Why?
|
Chronic Disease | 3 | 2010 | 9144 | 0.030 |
Why?
|
Peptides | 1 | 2006 | 4392 | 0.030 |
Why?
|
Immunity, Active | 1 | 2013 | 60 | 0.030 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2006 | 534 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2003 | 1513 | 0.030 |
Why?
|
Fluorouracil | 1 | 2018 | 1615 | 0.030 |
Why?
|
Graft Survival | 1 | 2004 | 3733 | 0.030 |
Why?
|
Prospective Studies | 5 | 2023 | 53187 | 0.030 |
Why?
|
Obesity | 2 | 2009 | 12705 | 0.030 |
Why?
|
Remission Induction | 2 | 2014 | 2384 | 0.030 |
Why?
|
Hepatocytes | 3 | 2006 | 1209 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 341 | 0.030 |
Why?
|
Dexamethasone | 2 | 2015 | 1949 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 804 | 0.030 |
Why?
|
Infant | 5 | 2009 | 35070 | 0.030 |
Why?
|
eIF-2 Kinase | 1 | 2013 | 150 | 0.030 |
Why?
|
Interleukin-23 | 1 | 2014 | 193 | 0.030 |
Why?
|
Carbohydrate Metabolism | 1 | 2014 | 264 | 0.030 |
Why?
|
Virulence | 1 | 2016 | 1328 | 0.030 |
Why?
|
Ischemia | 1 | 2001 | 1911 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2008 | 4933 | 0.030 |
Why?
|
Embryo, Nonmammalian | 2 | 2007 | 894 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2008 | 1158 | 0.030 |
Why?
|
Chemokine CXCL6 | 1 | 2012 | 13 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2022 | 39004 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1683 | 0.030 |
Why?
|
Antibodies | 1 | 2001 | 2459 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2003 | 4839 | 0.030 |
Why?
|
Up-Regulation | 2 | 2017 | 4211 | 0.030 |
Why?
|
Receptors, CXCR | 1 | 2012 | 52 | 0.030 |
Why?
|
Antibodies, Monoclonal | 3 | 2004 | 9274 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2012 | 226 | 0.030 |
Why?
|
Adoptive Transfer | 2 | 2006 | 844 | 0.030 |
Why?
|
Survival Analysis | 3 | 2012 | 10248 | 0.030 |
Why?
|
Unfolded Protein Response | 1 | 2013 | 230 | 0.030 |
Why?
|
Leukocytes | 2 | 2013 | 2039 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2005 | 7721 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2001 | 1860 | 0.020 |
Why?
|
Peroxidase | 2 | 2005 | 610 | 0.020 |
Why?
|
Immunoblotting | 2 | 2006 | 1683 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 3 | 2004 | 1837 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2002 | 3769 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 1999 | 2906 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3862 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2004 | 2049 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7153 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2502 | 0.020 |
Why?
|
Pituitary Neoplasms | 1 | 1999 | 1340 | 0.020 |
Why?
|
Enterohepatic Circulation | 1 | 2010 | 11 | 0.020 |
Why?
|
Mice, Inbred CFTR | 1 | 2010 | 19 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2016 | 1119 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2015 | 804 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2004 | 2274 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2014 | 947 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3471 | 0.020 |
Why?
|
Carcinoma, Ehrlich Tumor | 1 | 1969 | 24 | 0.020 |
Why?
|
Abdominal Pain | 2 | 2009 | 1059 | 0.020 |
Why?
|
Duodenum | 2 | 2009 | 483 | 0.020 |
Why?
|
Gadolinium DTPA | 2 | 2003 | 836 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2013 | 5975 | 0.020 |
Why?
|
Apolipoproteins B | 1 | 1991 | 373 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2002 | 766 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2017 | 1402 | 0.020 |
Why?
|
Electrophoresis | 1 | 1969 | 240 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2009 | 95 | 0.020 |
Why?
|
Neutrophils | 2 | 2015 | 3711 | 0.020 |
Why?
|
Cell Line | 2 | 2014 | 15994 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 2004 | 1950 | 0.020 |
Why?
|
Receptor, IGF Type 2 | 1 | 1989 | 35 | 0.020 |
Why?
|
Carcinoma, Islet Cell | 1 | 2009 | 22 | 0.020 |
Why?
|
Gene Silencing | 2 | 2008 | 1538 | 0.020 |
Why?
|
Receptors, Somatomedin | 1 | 1989 | 57 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2014 | 971 | 0.020 |
Why?
|
Gene Deletion | 1 | 2017 | 2751 | 0.020 |
Why?
|
Base Sequence | 3 | 2004 | 12797 | 0.020 |
Why?
|
Genomics | 1 | 2005 | 5692 | 0.020 |
Why?
|
Coated Pits, Cell-Membrane | 1 | 1989 | 78 | 0.020 |
Why?
|
DNA Primers | 2 | 2005 | 2892 | 0.020 |
Why?
|
Radiography | 1 | 2020 | 7010 | 0.020 |
Why?
|
Mice, Inbred AKR | 1 | 2008 | 107 | 0.020 |
Why?
|
Organic Anion Transporters, Sodium-Dependent | 1 | 2008 | 26 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 407 | 0.020 |
Why?
|
Blotting, Western | 2 | 2008 | 5180 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3504 | 0.020 |
Why?
|
Interleukin-4 | 2 | 2002 | 1146 | 0.020 |
Why?
|
RNA | 2 | 2007 | 2747 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 2552 | 0.020 |
Why?
|
Venous Pressure | 1 | 2008 | 56 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2010 | 391 | 0.020 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2008 | 106 | 0.020 |
Why?
|
Cohort Studies | 5 | 2012 | 40450 | 0.020 |
Why?
|
Gastrointestinal Hormones | 1 | 2008 | 97 | 0.020 |
Why?
|
Ribonucleoproteins, Small Nuclear | 1 | 1988 | 72 | 0.020 |
Why?
|
Transplantation, Homologous | 2 | 2008 | 4771 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4328 | 0.020 |
Why?
|
Cholesterol, Dietary | 1 | 2008 | 231 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2004 | 3770 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2003 | 3497 | 0.020 |
Why?
|
Radiation Chimera | 1 | 2007 | 223 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 766 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1989 | 1159 | 0.020 |
Why?
|
Paraffin Embedding | 1 | 2008 | 299 | 0.020 |
Why?
|
Activin Receptors, Type I | 1 | 2008 | 142 | 0.020 |
Why?
|
Heterozygote | 2 | 2007 | 2790 | 0.020 |
Why?
|
Antigens, Nuclear | 1 | 2008 | 192 | 0.020 |
Why?
|
Pyruvate Kinase | 1 | 2009 | 189 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2009 | 6534 | 0.020 |
Why?
|
Sulfonamides | 1 | 2016 | 1932 | 0.020 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2007 | 63 | 0.020 |
Why?
|
Spleen | 2 | 2004 | 2359 | 0.020 |
Why?
|
Nucleotides | 1 | 1969 | 463 | 0.020 |
Why?
|
K562 Cells | 1 | 2008 | 632 | 0.020 |
Why?
|
Hydroxylation | 1 | 2006 | 141 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2008 | 2915 | 0.020 |
Why?
|
RNA Editing | 1 | 2008 | 148 | 0.020 |
Why?
|
DNA Modification Methylases | 1 | 2007 | 206 | 0.020 |
Why?
|
Dopamine | 1 | 2014 | 1589 | 0.020 |
Why?
|
Listeria monocytogenes | 1 | 2008 | 250 | 0.020 |
Why?
|
Ploidies | 1 | 2007 | 281 | 0.020 |
Why?
|
Protein Conformation | 1 | 2014 | 4013 | 0.020 |
Why?
|
Mice, SCID | 2 | 2002 | 2715 | 0.020 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2008 | 301 | 0.020 |
Why?
|
Phylogeny | 1 | 2014 | 2797 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2007 | 322 | 0.020 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2006 | 57 | 0.020 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2008 | 537 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9679 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 7790 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2012 | 2723 | 0.020 |
Why?
|
Carbon Tetrachloride | 1 | 2006 | 64 | 0.020 |
Why?
|
Phenotype | 4 | 2006 | 16331 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 310 | 0.020 |
Why?
|
Neoplasms | 2 | 2005 | 21596 | 0.020 |
Why?
|
Cell Line, Tumor | 3 | 2008 | 16665 | 0.020 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2007 | 224 | 0.020 |
Why?
|
Microsatellite Repeats | 1 | 2008 | 800 | 0.020 |
Why?
|
Burkitt Lymphoma | 1 | 1988 | 328 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2009 | 1583 | 0.020 |
Why?
|
Heart Failure | 1 | 2009 | 10856 | 0.020 |
Why?
|
Swine | 2 | 2007 | 5934 | 0.020 |
Why?
|
Cyclin B | 1 | 2005 | 108 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2003 | 25575 | 0.020 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2005 | 55 | 0.020 |
Why?
|
Symporters | 1 | 2008 | 363 | 0.020 |
Why?
|
Mastocytosis | 1 | 2007 | 160 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2007 | 349 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 1989 | 18112 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2008 | 689 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2008 | 647 | 0.020 |
Why?
|
Hypertrophy | 1 | 2007 | 568 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2008 | 592 | 0.020 |
Why?
|
Base Pair Mismatch | 1 | 2004 | 97 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2020 | 3695 | 0.020 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2004 | 70 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2008 | 1589 | 0.020 |
Why?
|
Swine, Miniature | 1 | 2007 | 961 | 0.020 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2004 | 42 | 0.020 |
Why?
|
Zebrafish | 2 | 2007 | 2990 | 0.020 |
Why?
|
Trichosporon | 1 | 2004 | 8 | 0.020 |
Why?
|
Antigens, Surface | 1 | 2009 | 1663 | 0.020 |
Why?
|
Incidental Findings | 1 | 2009 | 688 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 1988 | 914 | 0.020 |
Why?
|
Organ Specificity | 1 | 2009 | 2003 | 0.020 |
Why?
|
Thioguanine | 1 | 2003 | 46 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 12946 | 0.010 |
Why?
|
Pathology, Molecular | 1 | 2007 | 325 | 0.010 |
Why?
|
Killer Cells, Natural | 2 | 2004 | 2133 | 0.010 |
Why?
|
Siblings | 1 | 2008 | 854 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2006 | 936 | 0.010 |
Why?
|
Hemangioendothelioma | 1 | 2004 | 121 | 0.010 |
Why?
|
Stromal Cells | 1 | 2009 | 1353 | 0.010 |
Why?
|
Species Specificity | 1 | 2008 | 2479 | 0.010 |
Why?
|
Leukemic Infiltration | 1 | 2003 | 48 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2018 | 5163 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1372 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3612 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 678 | 0.010 |
Why?
|
Daunorubicin | 1 | 2003 | 149 | 0.010 |
Why?
|
Fallopian Tubes | 1 | 2004 | 182 | 0.010 |
Why?
|
Autoantigens | 1 | 1988 | 891 | 0.010 |
Why?
|
Epidermis | 1 | 2006 | 527 | 0.010 |
Why?
|
Lymphocyte Transfusion | 1 | 2004 | 235 | 0.010 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2004 | 200 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2008 | 1526 | 0.010 |
Why?
|
Myelodysplastic Syndromes | 2 | 2003 | 1351 | 0.010 |
Why?
|
Proctoscopy | 1 | 2003 | 42 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3510 | 0.010 |
Why?
|
Endosonography | 1 | 2007 | 610 | 0.010 |
Why?
|
Prednisolone | 1 | 2003 | 333 | 0.010 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2003 | 283 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2005 | 579 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2372 | 0.010 |
Why?
|
Genes, RAG-1 | 1 | 2002 | 68 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2014 | 2896 | 0.010 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2002 | 45 | 0.010 |
Why?
|
Point Mutation | 1 | 2008 | 1624 | 0.010 |
Why?
|
Calcitonin | 1 | 2004 | 336 | 0.010 |
Why?
|
Giant Cells | 1 | 2003 | 187 | 0.010 |
Why?
|
Splenectomy | 1 | 2004 | 395 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2006 | 578 | 0.010 |
Why?
|
Etoposide | 1 | 2003 | 637 | 0.010 |
Why?
|
Cattle | 1 | 2008 | 3923 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 916 | 0.010 |
Why?
|
Homozygote | 1 | 2007 | 1777 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2004 | 279 | 0.010 |
Why?
|
Apoptosis | 2 | 2008 | 9715 | 0.010 |
Why?
|
Suture Techniques | 1 | 2007 | 797 | 0.010 |
Why?
|
Graft vs Host Reaction | 1 | 2001 | 103 | 0.010 |
Why?
|
Retinoblastoma Protein | 1 | 2005 | 701 | 0.010 |
Why?
|
Ovariectomy | 1 | 2004 | 660 | 0.010 |
Why?
|
Tyrosine | 1 | 2006 | 1460 | 0.010 |
Why?
|
Collagen Type III | 1 | 2002 | 90 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2004 | 595 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2004 | 430 | 0.010 |
Why?
|
Postoperative Period | 1 | 2007 | 1839 | 0.010 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2002 | 298 | 0.010 |
Why?
|
Cytarabine | 1 | 2003 | 684 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2002 | 217 | 0.010 |
Why?
|
Interphase | 1 | 2002 | 224 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5212 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4982 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2004 | 1827 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2007 | 1086 | 0.010 |
Why?
|
Protein Subunits | 1 | 2005 | 960 | 0.010 |
Why?
|
Cadherins | 1 | 2006 | 906 | 0.010 |
Why?
|
Colon, Sigmoid | 1 | 2002 | 118 | 0.010 |
Why?
|
Protein Phosphatase 1 | 1 | 2002 | 137 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 424 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2006 | 1586 | 0.010 |
Why?
|
Organ Size | 1 | 2006 | 2253 | 0.010 |
Why?
|
Interleukin-5 | 1 | 2002 | 273 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1835 | 0.010 |
Why?
|
Telomerase | 1 | 2006 | 729 | 0.010 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2002 | 162 | 0.010 |
Why?
|
src Homology Domains | 1 | 2002 | 364 | 0.010 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2002 | 234 | 0.010 |
Why?
|
Cyclosporine | 1 | 2003 | 784 | 0.010 |
Why?
|
Blood Vessels | 1 | 2006 | 1124 | 0.010 |
Why?
|
Bronchial Hyperreactivity | 1 | 2002 | 319 | 0.010 |
Why?
|
Fatty Acids | 1 | 2008 | 1806 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2015 | 62966 | 0.010 |
Why?
|
Pancreatic Ducts | 1 | 2002 | 328 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6365 | 0.010 |
Why?
|
HeLa Cells | 1 | 2006 | 3127 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2004 | 1262 | 0.010 |
Why?
|
Binding Sites | 1 | 1989 | 6115 | 0.010 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2002 | 315 | 0.010 |
Why?
|
Polycythemia | 1 | 2001 | 126 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1988 | 6313 | 0.010 |
Why?
|
Risk Factors | 2 | 2010 | 72145 | 0.010 |
Why?
|
Bone Marrow | 1 | 2010 | 2941 | 0.010 |
Why?
|
Ovary | 1 | 2004 | 981 | 0.010 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2002 | 473 | 0.010 |
Why?
|
Bromocriptine | 1 | 1999 | 111 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 56350 | 0.010 |
Why?
|
Fibrosis | 1 | 2006 | 2026 | 0.010 |
Why?
|
Hormone Antagonists | 1 | 1999 | 107 | 0.010 |
Why?
|
Antifungal Agents | 1 | 2004 | 729 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2007 | 19223 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2004 | 1849 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1988 | 2968 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5062 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2008 | 3199 | 0.010 |
Why?
|
Abdominal Injuries | 1 | 2001 | 352 | 0.010 |
Why?
|
Transfection | 1 | 2006 | 5892 | 0.010 |
Why?
|
Cell Cycle | 1 | 2007 | 2964 | 0.010 |
Why?
|
Germ-Line Mutation | 1 | 2006 | 1786 | 0.010 |
Why?
|
Gene Targeting | 1 | 2002 | 880 | 0.010 |
Why?
|
Albumins | 1 | 2001 | 568 | 0.010 |
Why?
|
Cell Division | 1 | 2005 | 4564 | 0.010 |
Why?
|
Cysts | 1 | 2003 | 676 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2004 | 1144 | 0.010 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2006 | 1509 | 0.010 |
Why?
|
Hedgehog Proteins | 1 | 2002 | 781 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2004 | 1780 | 0.010 |
Why?
|
Neurofilament Proteins | 1 | 1999 | 318 | 0.010 |
Why?
|
Drug Combinations | 1 | 2003 | 1961 | 0.010 |
Why?
|
Prolactin | 1 | 1999 | 669 | 0.010 |
Why?
|
Ion Channels | 1 | 2002 | 1056 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2004 | 1613 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1989 | 13814 | 0.010 |
Why?
|
Antigens | 1 | 2002 | 1462 | 0.010 |
Why?
|
Thyroid Gland | 1 | 2004 | 1172 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2002 | 1224 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2005 | 8925 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2008 | 8300 | 0.010 |
Why?
|
Colectomy | 1 | 2001 | 681 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2008 | 2130 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 2006 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 9846 | 0.010 |
Why?
|
Erythropoietin | 1 | 2001 | 724 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2006 | 2410 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2008 | 2736 | 0.010 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2003 | 1130 | 0.010 |
Why?
|
Pilot Projects | 1 | 2009 | 8297 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6259 | 0.010 |
Why?
|
Diarrhea | 1 | 2003 | 1343 | 0.010 |
Why?
|
Protein Binding | 1 | 1988 | 9387 | 0.010 |
Why?
|
Body Weight | 1 | 2006 | 4664 | 0.010 |
Why?
|
DNA Repair | 1 | 2004 | 2042 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2008 | 4664 | 0.010 |
Why?
|
Clostridium Infections | 1 | 2001 | 548 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12242 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 1999 | 974 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4029 | 0.010 |
Why?
|
Allergens | 1 | 2002 | 1314 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2002 | 1101 | 0.010 |
Why?
|
Sex Factors | 1 | 2008 | 10392 | 0.010 |
Why?
|
Time Factors | 3 | 2004 | 40054 | 0.010 |
Why?
|
Dietary Fats | 1 | 2002 | 2017 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6483 | 0.010 |
Why?
|
Aging | 1 | 2012 | 8626 | 0.010 |
Why?
|
Prevalence | 1 | 2009 | 15194 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2001 | 1327 | 0.010 |
Why?
|
Cell Membrane | 1 | 2002 | 3744 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2009 | 21719 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8621 | 0.010 |
Why?
|
Temporal Lobe | 1 | 1999 | 1669 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2002 | 2906 | 0.010 |
Why?
|
Rats | 1 | 2008 | 24265 | 0.010 |
Why?
|
Carcinoma | 1 | 2002 | 2374 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1991 | 918 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1991 | 829 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 23320 | 0.010 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 1969 | 87 | 0.010 |
Why?
|
Dialysis | 1 | 1969 | 75 | 0.010 |
Why?
|
Phosphorus Isotopes | 1 | 1969 | 126 | 0.010 |
Why?
|
Chemical Precipitation | 1 | 1969 | 180 | 0.010 |
Why?
|
Chemistry | 1 | 1969 | 352 | 0.010 |
Why?
|
Acrylates | 1 | 1969 | 89 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1991 | 1581 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1969 | 517 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2008 | 12220 | 0.010 |
Why?
|
Methods | 1 | 1969 | 1128 | 0.010 |
Why?
|
Culture Techniques | 1 | 1969 | 554 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2002 | 4465 | 0.010 |
Why?
|
Ribonucleases | 1 | 1969 | 287 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 15494 | 0.010 |
Why?
|
Gels | 1 | 1969 | 427 | 0.010 |
Why?
|
Survival Rate | 1 | 2002 | 12773 | 0.000 |
Why?
|
Algorithms | 1 | 2007 | 13853 | 0.000 |
Why?
|
Ribosomes | 1 | 1969 | 499 | 0.000 |
Why?
|
Phosphates | 1 | 1969 | 786 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2009 | 11695 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 13655 | 0.000 |
Why?
|
United States | 1 | 2007 | 69693 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2001 | 15244 | 0.000 |
Why?
|